iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis

Jan.14.2025
iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis
iJOY launches innovative three-tank e-cigarette, iJOY Lio SS40000, with adjustable ice and sweetness levels in the US market.

Special announcement:

This article is for internal industry communication only and does not make any recommendations for brands or products.

The images presented in this article are only used to depict facts and are not intended as advertisements for any products.

This article prohibits minors from accessing it.


 

iJOY recently launched a new e-cigarette model called the iJOY Lio SS40000, featuring a triple-pod design that allows for adjustable cooling and sweetness levels. The product has already hit the market in the United States.

 

iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis
iJOY Lio SS40000 | Image source: worldvapeusa

 

Specifically, the product specifications of iJOY Lio SS40000 are as shown in the table below.

iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis
iJOY Lio SS40000 Product Information | Design: Two to Supreme

 

The main feature of the iJOY Lio SS40000 e-cigarette is its three-pod system design. According to the manufacturer's website, the product includes a total of four ice levels and three sweetness options, allowing users to adjust both independently using two dedicated buttons.

 

In addition, the iJOY Lio SS40000 also features a 3D curved side screen, which can display battery level, e-liquid remaining amount, and monitor information such as ice level and sweetness level.

 

In December, Shenzhen Donghaoxing Technology Co., Ltd.'s e-cigarette brand Artery Vapor also launched a three-pod design e-cigarette, the Artery CL6 Sweet & Ice Control 50K, in the US market. This product also allows for adjusting the level of sweetness and ice. However, compared to the iJOY Lio SS40000, the Artery CL6 Sweet & Ice Control 50K has advantages in terms of the number of puffs and e-liquid capacity. (For more details, please refer to the article "Product | Three-pod design disposable e-cigarette launches in the US, offering adjustable ice and sweetness levels").

 

In the first half of 2024, iJoy has launched the e-cigarette iJoy Bar SD40000 in the United States, which has a capacity of 40,000 puffs. This product is among the first batch of e-cigarettes in the U.S. market to have a puff capacity of 40,000. Up to now, the performance of iJoy's e-cigarette products in terms of puff capacity has not seen any new breakthroughs. (For more details, please refer to "Product | iJoy launches 40,000 puff disposable e-cigarette in the U.S. with support for AI voice control")

 

The iJOY Lio SS40000 has landed on e-cigarette distributor websites such as vapesourcing, midwestgoods, and worldvapeusa, but is currently not available on the official iJOY website.

 


2Firsts will continue to monitor the performance and market trends of global e-cigarette products, providing the public with accurate and authoritative industry information.

 

2FIRSTS is a product column dedicated to providing readers with the latest information on new products in the tobacco industry. In order to collect and share first-hand information from the industry more broadly, 2FIRSTS welcomes readers to submit articles and share the latest products in the e-cigarette field with us.

 

If you have any unique insights or information, please feel free to contact us at info@2firsts.com at any time.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
The Global State of Tobacco Harm Reduction, a project operated by Knowledge·Action·Change, estimates that about 200 million people worldwide use non-combustible nicotine products including vapes, heated tobacco, nicotine pouches and snus. Its 2026 report says use of these products rose alongside declining smoking rates in 28 countries it analyzed. The data do not establish that all 200 million users have quit smoking, nor do they prove a direct causal relationship. GSTHR also says regulatory restrictions on the products continue to expand in many markets.
Sep.10
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Swedish nicotine pouch brand Kelly White is building its strategy around adult female consumers. Founder and CEO Sophia Wilsby told 2Firsts that women accounted for around 70% of the brand’s repeat customers on HAYPP in Sweden in 2025. The interview explores female consumer segmentation, product and design differentiation, gender stereotypes, packaging regulation, and how independent brands can compete with global players such as ZYN and VELO while considering funding, partnerships and future ownership options.
Business
Sep.24
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
Bret Koplow, acting director of the U.S. Food and Drug Administration's Center for Tobacco Products, will deliver a keynote and participate in a fireside chat at the National Association of Tobacco Outlets' Sept. 29-30 conference in Washington. His appearance comes months after the FDA moved to accelerate PMTA reviews and introduced a more differentiated enforcement policy for certain unauthorized ENDS and oral nicotine pouch products. The agency also plans a public list identifying manufacturers and products it does not currently intend to prioritize for enforcement under the May guidance. NATO says its membership includes more than 66,000 retail stores, making product-status transparency and enforcement boundaries directly relevant to the retail sector.
Aug.14
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
European Ombudswoman Teresa Anjinho has opened an inquiry into how the European Commission’s Directorate-General for Trade handles interactions with the tobacco industry. The case follows a complaint from a civil society organisation that alleges regular, unnecessary and non-transparent contacts between DG TRADE and tobacco industry representatives, raising questions over compliance with the EU’s obligations under the WHO Framework Convention on Tobacco Control. The inquiry remains ongoing, and the Ombudswoman has not reached any finding of maladministration.
Aug.24